Poolbeg Pharma plc (LON:POLB, OTCQB: POLBF), a biopharmaceutical company focussed on the development and commercialisation of innovative medicines targeting diseases with a high unmet medical need, has announced that the Company has changed its registered address to 40 Bank Street, Floor 24, London, E14 5NR, United Kingdom.
Poolbeg Pharma relocates to new London headquarters at 40 Bank Street
[shareaholic app="share_buttons" id_name="post_below_content"]
- Written by: Amilia Stone
Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
Poolbeg Pharma to showcase POLB 001's promising results in reducing CRS at ASH 2024, highlighting breakthroughs in cancer immunotherapy safety.
Discover six high-growth AIM-listed British companies delivering exceptional returns, with share prices surging up to 150% in the past year.
Poolbeg Pharma plc (LON:POLB) investor presentation with CEO Jeremy Skillington. Insights on company overview, key programs, progress in 2023, and market opportunities.
Poolbeg Pharma plc (LON: POLB, OTCQB: POLBF) announces the posting of its Annual Report and Accounts, with details of the upcoming Annual General Meeting on June 13, 2024.